SCHEMBL30652952

SCHEMBL30652952

CC(C)CCC[C@@H](C)[C@H]1CC[C@@]23O[C@]24C=C[C@@]25C[C@@H](O)CC[C@]2(C)[C@]4(CC[C@]13C)OO5

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EBP Q15125 7/20 0.41
▸ NPC1L1 Q9UHC9 4/20 0.36
▸ PLA2G1B P04054 1/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ USP2 O75604 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CXCR1 P25024 1/20 0.35
▸ RORC P51449 3/20 0.34
▸ RORA P35398 3/20 0.34
▸ GPR183 P32249 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ OSBP P22059 1/20 0.34
▸ OSBP2 Q969R2 1/20 0.34
▸ CYP46A1 Q9Y6A2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30653161 0.67 PLA2G1B (0.55) NPC1L1PLA2G1BMEN1KMT2AUSP2
SCHEMBL16152196 0.67 PLA2G1B (0.55) NPC1L1PLA2G1BMEN1KMT2AUSP2
SCHEMBL8408231 0.67 PLA2G1B (0.55) NPC1L1PLA2G1BMEN1KMT2AUSP2
SCHEMBL18199154 0.66 EBP (0.52) EBPNPC1L1PLA2G1BMEN1KMT2A
SCHEMBL17487215 0.66 EBP (0.55) EBPNPC1L1PLA2G1BMEN1KMT2A
SCHEMBL18714858 0.66 EBP (0.55) EBPNPC1L1PLA2G1BMEN1KMT2A
SCHEMBL18714859 0.66 EBP (0.55) EBPNPC1L1PLA2G1BMEN1KMT2A
SCHEMBL17487216 0.66 EBP (0.55) EBPNPC1L1PLA2G1BMEN1KMT2A
SCHEMBL14129628 0.63 RORC (0.46) EBPNPC1L1MEN1KMT2AUSP2
SCHEMBL13185816 0.60 EBP (0.55) EBPNPC1L1PLA2G1BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522646-A2 APOE LIPOPROTEIN SYSTEMS Kisbee Therapeutics, Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
Send feedback